About Anifrolumab
            
            Class: | Monoclonal antibody (IgG1κ)  
Use: | Treatment of moderate to severe systemic lupus erythematosus (SLE) in adults  
Adult dose: | 300 mg administered as an intravenous infusion every 4 weeks after an initial loading dose of 300 mg at weeks 0, 2, and 4  
Pediatric dose: | Safety and efficacy not established in pediatric patients; not recommended for use in individuals under 18 years of age  
Side effects: | Common side effects include upper respiratory infections, headache, infusion-rela
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (IgG1κ)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of moderate to severe systemic lupus erythematosus (SLE) in adults
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light; may be stored at room temperature (up to 25°C or 77°F) for a maximum of 48 hours prior to use
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: AstraZeneca AB. [Sodertalje;Sweden], Sweden
                    
                    
                    Package Size
                    1 Glass Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 5128.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        300 mg administered as an intravenous infusion every 4 weeks after an initial loading dose of 300 mg at weeks 0, 2, and 4
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; not recommended for use in individuals under 18 years of age
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include upper respiratory infections, headache, infusion-related reactions, nausea, and fatigue
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to anifrolumab or any component of the formulation; active infections (e.g., tuberculosis) should be treated prior to initiation
         
        
        
            
                Important Warnings
            
            Risk of serious infections; monitor for signs of infection; may cause hypersensitivity reactions; caution in patients with a history of malignancy; not recommended for use in patients with severe hepatic impairment
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.